Xavier de Leval
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 35
- Inflammatory mediators and NSAID effects 35
-
- Synthesis and biological activity 10
- Synthesis and Reactions of Organic Compounds 4
- Synthesis and Catalytic Reactions 3
- Co-authors
- Bernard Pirotte (33 shared papers)Jean‐Michel Dogné (30 shared papers)Fabien Julémont (13 shared papers)J. Delarge (12 shared papers)Bernard Masereel (7 shared papers)Jean‐Louis David (7 shared papers)Julien Hanson (7 shared papers)Vincent Castronovo (3 shared papers)
- Journals
- Current Medicinal Chemistry (7 papers)Expert Opinion on Therapeutic Patents (6 papers)Journal of Medicinal Chemistry (5 papers)Prostaglandins Leukotrienes and Essential Fatty Acids (4 papers)Mini-Reviews in Medicinal Chemistry (4 papers)
- Partner nations
- BelgiumNew ZealandFrance
In The Last Decade
Xavier de Leval
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 532
- Biochemistry 149
- Organic Chemistry 430
- Pharmacology 96
- Toxicology 36
Countries citing papers authored by Xavier de Leval
This map shows the geographic impact of Xavier de Leval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier de Leval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier de Leval more than expected).
Fields of papers citing papers by Xavier de Leval
This network shows the impact of papers produced by Xavier de Leval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier de Leval. The network helps show where Xavier de Leval may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier de Leval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 122 | |
| 2 | 2002 | 103 | |
| 3 | 2004 | 68 | |
| 4 | 2004 | 67 | |
| 5 | 2004 | 65 | |
| 6 | 2004 | 65 | |
| 7 | 2000 | 53 | |
| 8 | 2002 | 48 | |
| 9 | 2006 | 47 | |
| 10 | 2002 | 47 | |
| 11 | 2004 | 42 | |
| 12 | 2006 | 41 | |
| 13 | 2003 | 39 | |
| 14 | 2002 | 35 | |
| 15 | 2006 | 35 | |
| 16 | 2004 | 34 | |
| 17 | 2000 | 32 | |
| 18 | 2014 | 32 | |
| 19 | 2004 | 32 | |
| 20 | 2001 | 31 |
About Xavier de Leval
Xavier de Leval is a scholar working on Pharmacology, Organic Chemistry, Biochemistry, Genetics and Cardiology and Cardiovascular Medicine, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (35 papers), Estrogen and related hormone effects (14 papers), Synthesis and biological activity (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Synthesis and Reactions of Organic Compounds (4 papers), Enzyme function and inhibition (3 papers) and Synthesis and Catalytic Reactions (3 papers). The work is most often cited by research in Pharmacology (532 citations), Biochemistry (149 citations), Organic Chemistry (430 citations), Pharmacology (96 citations) and Toxicology (36 citations). Xavier de Leval has collaborated with scholars based in Belgium, New Zealand and France. Frequent co-authors include Bernard Pirotte, Jean‐Michel Dogné, Fabien Julémont, J. Delarge, Bernard Masereel, Jean‐Louis David, Julien Hanson, Vincent Castronovo, David Waltregny and Bernard Masereel. Their work appears in journals such as Current Medicinal Chemistry, Expert Opinion on Therapeutic Patents, Journal of Medicinal Chemistry, Prostaglandins Leukotrienes and Essential Fatty Acids and Mini-Reviews in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.